mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.05 |